SMALL CAP SHARE IDEAS: Ergomed set to benefit from Covid-19 trials
Spikes in infection rates and second wave fears point to the battle against coronavirus being a long one. To tackle the virus, will most almost certainly require the development of a vaccine and new treatments for the people affected. As well as the drugs themselves, that will mean more help from the companies providing clinical … Read more